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absorbance correlates with the amount of exposed myc epitope and thus can be used to calculate the 154 amount of membrane-inserted myc-Glut4-GFP. 155 156 Two-dimensional differential in gel electrophoresis (2D-DIGE), matrix-assisted laser desorption 157 ionization time of flight (MALDI-TOF) mass spectrometry, and functional clustering. Differential protein 158 expression using 2D-DIGE comparing wild-type and CHIP-deficient mouse embryonic fibroblast protein 159 extracts was carried out as previously described (44) . 34 spots identified via 2D-DIGE (unpaired t-test, p 160 < 0.05, FDR < 25%) were identified via MALDI-TOF mass spectrometry and analyzed using the DAVID 161 functional annotation clustering tool (14, 21) . The mean fold-enrichment (log2) of each functional cluster 162 (x-axis) and corresponding proteins (y-axis) were analyzed using a Pearson's centered, complete linkage 163 clustering analysis as previously described (8).
165
Single muscle fiber preparation. Wild-type and CHIP-deficient mice were fasted overnight and split into 166 two groups. The first group of mice maintained the fast, whereas the second received an IP injection of 167 20% D-glucose (2 µg glucose/g body mass). After 40 min, mice were sacrificed by cervical dislocation, 168 and the gastrocnemius was immediately removed and placed in 2% paraformaldehyde (w/v) for 1 h, then 169 rinsed several times in PBS. Small bundles of 1-3 fibers were then teased away with fine forceps. 
174
CHIP is necessary for optimal glucose homeostasis. CHIP-deficient mice demonstrate an accelerated 175 aging phenotype as well as other maladies, including muscle wasting, that suggest metabolic imbalances 176 (35) . Given the high level of CHIP expression detected in human skeletal muscle (4), the association 177 between muscle atrophy and altered glucose homeostasis (47), and the established link between the loss may have altered glucose homeostasis stemming from skeletal muscle dysfunction. Consistent with our 180 hypothesis, mice lacking CHIP exhibited a mild hyperglycemia that was more pronounced under fasted 181 conditions (Fig. 1A) . The change in glucose homeostasis was accompanied by a trend towards an increase 182 in insulin levels that was unmasked in the fed state ( Fig. 1A ), suggesting that decreased insulin 183 responsiveness in the peripheral tissues of CHIP-deficient mice may result in compensatory 184 hyperinsulinemia typical of Type II diabetes (18). To test this, a glucose tolerance test was performed on 185 wild-type and CHIP-deficient 129SvEv mice to determine the acute ability of tissues in these mice to 186 remove glucose from the blood. CHIP-deficient mice failed to clear glucose from the blood efficiently 187 compared to wild-type mice (48 ± 9% increase in the AUC comparing CHIP -/to wild-type mice, Fig. 
188
1B). To measure whether the defect in glucose tolerance was due to a reduction in insulin release or 189 insulin receptor sensitivity, an insulin tolerance test was performed. We found that intraperitoneal 190 administration of insulin had a smaller effect on lowering blood glucose levels in CHIP-deficient mice at 191 all time points tested (49 ± 6% increase in the AUC comparing CHIP -/to wild-type mice, Fig. 1C ), 192 suggesting that insulin sensitivity is impaired in CHIP -/mice. To directly assess insulin sensitivity, we 193 performed a hyperinsulinemic-euglycemic clamp assay. During insulin infusion, CHIP-deficient mice 194 required half the rate of glucose infusion compared to wild-type mice to maintain blood glucose levels 195 (Table 1) , indicating whole-body insulin resistance. This finding was supported by the fact that CHIP-196 deficient mice were unable to suppress hepatic glucose production to the same extent as wild-type mice, 197 and there was a dramatic reduction in the ability of CHIP-deficient gastrocnemius to take up 2-198 deoxyglucose during hyperinsulimia (45 ± 9%; Table 1 ). This poor glucose tolerance phenotype and 199 impaired glucose uptake in skeletal muscle was recapitulated in CHIP -/mice bred on a mixed C57BL/6 × 200 129 background ( Fig. 1D and Table 1 ). Taken together, these data demonstrate that the absence of CHIP 201 leads to a Type II diabetes-like phenotype under physiological conditions due to impaired glucose uptake 202 and insulin resistance in skeletal muscle.
CHIP is necessary for optimal Glut4 translocation to the membrane following insulin stimulation.
205
We hypothesized that the severe defect in glucose uptake associated with CHIP deficiency (Fig. 1B-D,   206   Table 1 ) may be linked to the inability of Glut4, the major glucose transporter found in skeletal muscle 207 and adipose tissue, to translocate from the cell interior to the plasma membrane in response to insulin 208 stimulation, thereby hindering the cellular uptake of glucose (22). Following insulin stimulation, a series 209 of intracellular signaling pathways promote Glut4 movement from intracellular vesicles to the cell 210 membrane (9). Once Glut4 reaches the cell membrane, it fuses and undergoes exocytosis to facilitate the 211 diffusion of glucose through the cell membrane. Glut4 translocation is essential for successful insulin 212 signaling and glucose uptake by skeletal muscle cells (23, 26, 39, 45, 51) . We employed lentiviral 213 transduction of control or CHIP shRNA in mouse skeletal muscle C2C12 cells (shCONT and shCHIP cell 214 lines) to investigate if a reduction in CHIP expression influences insulin-dependent Glut4 translocation.
215
To measure Glut4 translocation, we transfected shCONT and shCHIP C2C12 cells with a myc-Glut4-216 GFP construct (myc N-terminus, GFP C-terminus; (52) ) and examined the location of Glut4-GFP protein 217 following 4 h serum starvation before and after a challenge with 25 mM glucose and 100 nM insulin.
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After serum starvation and prior to glucose/insulin stimulation (time 0), Glut4-GFP was largely localized 219 to the perinuclear region in both the shCONT and shCHIP C2C12 cells ( Fig. 2A ). However, following 30 220 min of insulin stimulation, Glut4-GFP translocated to the membrane in shCONT cells, but remained in a 221 perinuclear region in the shCHIP cells ( Fig. 2A ). To verify this lack of Glut4 movement in response to 222 insulin in shCHIP cells, we took advantage of the myc tag on the Glut4-GFP construct and performed a 223 colorimetric assay of surface myc-Glut4-GFP using O-phenylenediamine dihydrochloride (OPD). In this 224 method, insertion of myc-Glut4-GFP protein into the cell membrane results in the exofacial positioning of 225 the myc tag. This tag is subsequently labeled with a secondary antibody conjugated to peroxidase and 226 then is treated with OPD reagent, which results in a colorimetric reaction that can be monitored by 227 measuring light absorbance at 492 nm (50). Using this assay, we confirmed that, whereas the membrane 228 level of myc-Glut4-GFP increased following insulin stimulation in shCONT cells, the amount of 229 membrane-bound myc-Glut4-GFP did not change following insulin stimulation in shCHIP cells (Fig. 2B ).
This lack of Glut4 translocation to the membrane in the shCHIP cells suggests that CHIP is involved in 231 insulin-dependent trafficking of Glut4 to the cell membrane. 232 233 CHIP deficiency results in cytoskeletal abnormalities in shCHIP C2C12 cells. The movement of 234 Glut4 to the cell membrane requires the coordinated assembly of both actin microfilaments and tubulin-shCHIP cells, even at later time points. Importantly, these data indicate a severe disruption in the ability 257 of tubulin to polymerize in response to insulin in CHIP-deficient C2C12 cells.
259
Stathmin phosphorylation is decreased in CHIP-deficient C2C12 cells. Because our data suggested 260 that tubulin polymerization is impaired in the absence of CHIP, we investigated whether other 261 cytoskeletal-associated proteins were reliant on CHIP expression. First, we identified proteins whose 262 steady-state protein levels were affected by CHIP expression by performing two-dimensional difference 263 gel electrophoresis (2D-DIGE) on protein extracts from primary wild-type and CHIP-deficient MEFs. We 264 identified Actin Cytoskeleton and Morphogenesis as one of the major classes of proteins differentially 265 regulated by CHIP expression ( Fig. 4A ). Included in this group of proteins was stathmin, a microtubule-266 associated protein that regulates the polymerization of tubulin (48). Stathmin levels were reduced in the 267 shCONT cells compared to the CHIP-deficient cells, suggesting that CHIP may directly affect stathmin 268 cellular function. Stathmin activity is regulated by both total levels and by phosphorylation.
269
Unphosphorylated stathmin binds to the αand β-tubulin dimers and helps to maintain a pool of tubulin 270 readily available for polymerization in the soluble fraction, but phosphorylation of stathmin prevents 271 stathmin from binding to tubulin dimers, thereby allowing tubulin polymerization (33, 40, 48) . To 272 determine if the phosphorylation of stathmin is impacted by CHIP expression in a cellular context where 273 tubulin reorganization is triggered, we measured stathmin serine 16 phosphorylation after serum 274 starvation and subsequent insulin stimulation (33). Following insulin stimulation, the level of 275 phosphorylated stathmin was increased in shCONT cells ( Fig. 4C-D) , coincident with the appearance of 276 polymerized tubulin ( Fig. 3B-C) . In contrast, a much smaller increase in phosphorylated stathmin was 277 seen in shCHIP cells, in agreement with an observed lack of polymerized tubulin in these cells. Taken 278 together, the decreased insulin sensitivity in CHIP-deficient mice and insufficient Glut4 translocation may 279 be caused by impaired stathmin phosphorylation and inadequate tubulin polymerization.
CHIP is necessary for optimal microtubule polymerization in vivo following insulin stimulation. To 282 determine if the lack of microtubule polymerization in CHIP-deficient C2C12 cells was recapitulated in 283 an in vivo setting, we examined microtubule polymerization in freshly isolated myofibers from CHIP-284 deficient mice. In response to insulin stimulation, microtubules within individual muscle fibers 285 longitudinally span myofibrils just beneath the sarcolemma and transversely across the myofibrils, with a 286 concentration in the area of the I-band leading to a lattice-like microtubule appearance (25). Microtubules 287 are also found in the perinuclear region and radiate from the perinuclear region to run transversely into 288 the interior of the myofibril, an arrangement that is purported to support intracellular transport (25). To 289 examine whether the microtubule arrangement is aberrant in CHIP-deficient muscle fibers following 290 insulin stimulation, we fasted wild-type and CHIP-deficient mice overnight and then challenged both 291 genotypes with an IP bolus of glucose. Neither wild-type nor CHIP-deficient myofibers displayed 292 substantial sub-sarcolemmal nor perinuclear α-tubulin staining after the overnight fast. However, after an 293 injection of glucose, the wild-type fibers exhibited intense perinuclear α-tubulin staining and a striking 294 lattice arrangement of α-tubulin-positive fibers at the surface of the sarcolemma (Fig. 5 ). In contrast, this 295 lattice appearance was strikingly absent in CHIP-deficient myofibers, revealing a lack of microtubule 296 polymerization at the myofiber surface ( Fig. 5 ). Taken together, we observe hyperglycemia and insulin 297 resistance in CHIP-deficient mice, and we demonstrate that shCHIP cells exhibit decreased microtubule 298 polymerization and Glut4 translocation. We propose that CHIP plays a critical role in promoting insulin-299 stimulated microtubule polymerization and the movement of Glut4 to the membrane, facilitating the 300 import of glucose into the cell and maintaining glucose homeostasis.
302

DISCUSSION
303
Glucose transporter translocation is an important cellular mechanism in glucose homeostasis, especially 304 in insulin-sensitive tissues such as skeletal muscle. Previously, we reported that mice lacking CHIP 305 expression exhibit phenotypes such as accelerated aging and decreased tolerance to cardiac stressors such 306 as ischemia reperfusion and pressure overload (35). Here we add to the characterization of the CHIP-deficient phenotype by demonstrating that CHIP-deficient mice also develop a Type II diabetic 308 phenotype, including glucose intolerance (Fig. 1B, 1D ), insulin resistance (Fig. 1C, Table 1 ), and 309 decreased glucose uptake in skeletal muscle (Table 1) . The apparent cause for this aberrant 310 glucose/insulin response is at least in part due to the disruption of microtubule reorganization in response 311 to insulin stimulation (Fig. 3A, 3B, 3C , and 5) that is necessary for the glucose transporter Glut4 to 312 translocate to the cell membrane and facilitate the entry of glucose into the cell (Fig 2A, 2B, and 3A) .
313
These data support the hypothesis that CHIP expression is necessary for maintaining optimal 314 glucose/insulin signaling and provides further evidence of an intersection between protein quality control 315 and metabolic pathways. 
